Literature DB >> 19758805

An "omics" approach to uropathogenic Escherichia coli vaccinology.

Kelsey E Sivick, Harry L T Mobley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19758805      PMCID： PMC2770165          DOI： 10.1016/j.tim.2009.07.003

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


× No keyword cloud information.
  14 in total

1.  Transcriptome of uropathogenic Escherichia coli during urinary tract infection.

Authors:  Jennifer A Snyder; Brian J Haugen; Eric L Buckles; C Virginia Lockatell; David E Johnson; Michael S Donnenberg; Rodney A Welch; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

2.  Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.

Authors:  Walter J Hopkins; Johny Elkahwaji; Lori M Beierle; Glen E Leverson; David T Uehling
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

3.  Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli.

Authors:  Amanda L Lloyd; David A Rasko; Harry L T Mobley
Journal:  J Bacteriol       Date:  2007-03-09       Impact factor: 3.490

4.  Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach.

Authors:  Swaine L Chen; Chia-Seui Hung; Jian Xu; Christopher S Reigstad; Vincent Magrini; Aniko Sabo; Darin Blasiar; Tamberlyn Bieri; Rekha R Meyer; Philip Ozersky; Jon R Armstrong; Robert S Fulton; J Phillip Latreille; John Spieth; Thomas M Hooton; Elaine R Mardis; Scott J Hultgren; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

5.  The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.

Authors:  Thomas A Russo; Catherine D McFadden; Ulrike B Carlino-MacDonald; Janet M Beanan; Ruth Olson; Gregory E Wilding
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 6.  Origins and virulence mechanisms of uropathogenic Escherichia coli.

Authors:  Travis J Wiles; Richard R Kulesus; Matthew A Mulvey
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

7.  Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine.

Authors:  Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2007-06       Impact factor: 3.441

Review 8.  The genome revolution in vaccine research.

Authors:  Barbara Capecchi; Davide Serruto; Jeannette Adu-Bobie; Rino Rappuoli; Mariagrazia Pizza
Journal:  Curr Issues Mol Biol       Date:  2004-01       Impact factor: 2.081

9.  Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli.

Authors:  Jeffrey P Henderson; Jan R Crowley; Jerome S Pinkner; Jennifer N Walker; Pablo Tsukayama; Walter E Stamm; Thomas M Hooton; Scott J Hultgren
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

10.  Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.

Authors:  Carmen Giefing; Andreas L Meinke; Markus Hanner; Tamás Henics; Minh Duc Bui; Dieter Gelbmann; Urban Lundberg; Beatrice M Senn; Michael Schunn; Andre Habel; Birgitta Henriques-Normark; Ake Ortqvist; Mats Kalin; Alexander von Gabain; Eszter Nagy
Journal:  J Exp Med       Date:  2007-12-31       Impact factor: 14.307
View more
  8 in total

Review 1.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

2.  Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Authors:  Patrick D Vigil; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

Review 3.  Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

Authors:  Ariel R Brumbaugh; Harry L T Mobley
Journal:  Expert Rev Vaccines       Date:  2012-06       Impact factor: 5.217

4.  Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.

Authors:  Ariel R Brumbaugh; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

Review 5.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

Review 6.  Urinary tract infections: current and emerging management strategies.

Authors:  Amelia E Barber; J Paul Norton; Adam M Spivak; Matthew A Mulvey
Journal:  Clin Infect Dis       Date:  2013-05-03       Impact factor: 9.079

7.  The high-pathogenicity island (HPI) promotes flagellum-mediated motility in extraintestinal pathogenic Escherichia coli.

Authors:  Giuseppe Magistro; Christiane Magistro; Christian G Stief; Sören Schubert
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

8.  Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells.

Authors:  Neha Dikshit; Pradeep Bist; Shannon N Fenlon; Niyas Kudukkil Pulloor; Christelle En Lin Chua; Marci A Scidmore; Jason A Carlyon; Bor Luen Tang; Swaine L Chen; Bindu Sukumaran
Journal:  PLoS Pathog       Date:  2015-08-06       Impact factor: 7.464
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.